Lynne Parshall

Lynne Parshall serves as a Board Member for multiple organizations, including Foghorn Therapeutics Inc., Ring Therapeutics, Repertoire Immune Medicines, and Ionis Pharmaceuticals, where Lynne chairs the Compliance Committee and has held various leadership roles since 1991. Additionally, Lynne is the Chief Executive Officer of Lyme Pinnacle, Inc. and has previously served as Board Chair for Akcea Therapeutics, overseeing its formation and IPO. Lynne's extensive experience includes strategic advisory services, senior executive roles at Ionis Pharmaceuticals, and a partnership at Cooley LLP, specializing in biotechnology. Lynne holds a Bachelor of Arts from Harvard University and a Juris Doctor from Stanford University.